Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2014 - 2016)

Viridian Therapeutics, Inc.\DE's Current Leases history runs 3 years deep, the most recent figure standing at $4000.0 for Q4 2016.

• On a quarterly basis, Current Leases fell 95.45% year-over-year to $4000.0 in Q4 2016; TTM through Dec 2016 was $4000.0, a 95.45% decrease from a year earlier, with the FY2016 full-year figure at $4000.0, down 95.45% from the prior year.
• Current Leases eased to $4000.0 in Q4 2016 per VRDN's latest filing, from $88000.0 in the prior quarter.
• Across five years, Current Leases topped out at $88000.0 in Q4 2015 and bottomed at $4000.0 in Q4 2016.
• The 3-year median for Current Leases is $80000.0 (2014), against an average of $57333.3.
• Across the five-year window, Current Leases advanced 10.0% in 2015 and tumbled 95.45% in 2016, its largest moves.
• Year by year, Current Leases stood at $80000.0 in 2014, then grew by 10.0% to $88000.0 in 2015, then tumbled by 95.45% to $4000.0 in 2016.
• Per Business Quant, the three latest VRDN Current Leases figures stand at $4000.0 (Q4 2016), $88000.0 (Q4 2015), and $80000.0 (Q4 2014).